Study finds bone density loss associated with levothyroxine
Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone loss, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).
Mursla Bio's EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced results of its multi-center clinical study, MEV01, in collaboration with leading academic institutes including University College London, Imperial College London, University Hospital of Santa Maria and the Medical University of Graz.
Study shows low dengue prevalence during COVID-19 in Tamil Nadu
Study analyzes low dengue prevalence during COVID-19, attributing it to possible viral interference and high SARS-CoV-2 IgG levels.
Physical activity essential at all stages of adult life
The research reveals that physical activity is key to lowering mortality risk, with stronger effects in older adults compared to other health factors over time.
History of endometriosis and fibroids linked to higher long-term risk of early death
Researchers examine the impact of endometriosis and uterine fibroids on the risk of early death.
Multiomic signatures identified for rapid detection and treatment of high-risk T-ALL
Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who have a higher risk version of the disease and are more likely to relapse despite treatment.
GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
Boosters cut long COVID risk significantly
Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.
Atlas maps plasma proteins to transform disease diagnosis and treatment
Researchers have developed the most comprehensive atlas linking plasma proteins to diseases and traits in over 53,000 individuals, offering groundbreaking insights for precision medicine. This resource uncovers 168,100 protein-disease associations and identifies new therapeutic targets.
Coffee reshapes Brazilian diets: sugar up, milk down, and health risks highlighted
Coffee consumption in Brazil influences dietary choices, increasing sugar and sweetener intake while reducing milk and sugar-sweetened beverage consumption, with notable gender differences and public health implications.
last updated on 26 Nov 07:11